Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Advisory Committees

-

Slides for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

FDA

FDA Core Presentations, QNEXA (phentermine/topiramate) Controlled Release Capsules, for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 964KB)

VIVUS, Inc

VIVUS Core Presentations, QNEXA (phentermine/topiramate) Controlled Release Capsules, for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 3.4MB)

VIVUS Backup Presentations, QNEXA (phentermine/topiramate) Controlled Release Capsules, for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 1.1MB)

Open Public Hearing

OPH Core Presentations, QNEXA (phentermine/topiramate) Controlled Release Capsules, for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 186KB)

-

-